KRAS c.328_330delinsTAA ;(p.P110*)

Variant ID: 12-25378668-AGG-TTA

NM_004985.3(KRAS):c.328_330delinsTAA;(p.P110*)

This variant was identified in 6 publications

View GRCh38 version.




Publications:


Genetic Mutations of Pancreatic Cancer and Genetically Engineered Mouse Models.

Cancers
Saiki, Yuriko Y; Jiang, Can C; Ohmuraya, Masaki M; Furukawa, Toru T
Publication Date: 2021-12-24

Variant appearance in text: KRAS: p110*
PubMed Link: 35008235
Variant Present in the following documents:
  • Main text
View BVdb publication page



Genetic Mutations of Pancreatic Cancer and Genetically Engineered Mouse Models.

Cancers
Saiki, Yuriko Y; Jiang, Can C; Ohmuraya, Masaki M; Furukawa, Toru T
Publication Date: 2021-12-24

Variant appearance in text: KRAS: p110*
PubMed Link: 35008235
Variant Present in the following documents:
  • Main text
View BVdb publication page



Development of syngeneic murine cell lines for use in immunocompetent orthotopic lung cancer models.

Cancer Cell International
Nolan, Kyle K; Verzosa, Gregory G; Cleaver, Tim T; Tippimanchai, Darinee D; DePledge, Lisa N LN; Wang, Xiao-Jing XJ; Young, Christian C; Le, Anh A; Doebele, Robert R; Li, Howard H; Malkoski, Stephen P SP
Publication Date: 2020

Variant appearance in text: KRAS: P110*
PubMed Link: 32874131
Variant Present in the following documents:
  • Main text
View BVdb publication page



Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations.

Molecular Cancer Research : Mcr
Foley, Tyler M TM; Payne, Susan N SN; Pasch, Cheri A CA; Yueh, Alex E AE; Van De Hey, Dana R DR; Korkos, Demetra P DP; Clipson, Linda L; Maher, Molly E ME; Matkowskyj, Kristina A KA; Newton, Michael A MA; Deming, Dustin A DA
Publication Date: 2017-02-09

Variant appearance in text: KRAS: p110*
PubMed Link: 28184015
Variant Present in the following documents:
  • Main text
View BVdb publication page



Colon Cancer Tumorigenesis Initiated by the H1047R Mutant PI3K.

Plos One
Yueh, Alexander E AE; Payne, Susan N SN; Leystra, Alyssa A AA; Van De Hey, Dana R DR; Foley, Tyler M TM; Pasch, Cheri A CA; Clipson, Linda L; Matkowskyj, Kristina A KA; Deming, Dustin A DA
Publication Date: 2016

Variant appearance in text: KRAS: p110*
PubMed Link: 26863299
Variant Present in the following documents:
  • Main text
View BVdb publication page



PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors.

Oncogenesis
Payne, S N SN; Maher, M E ME; Tran, N H NH; Van De Hey, D R DR; Foley, T M TM; Yueh, A E AE; Leystra, A A AA; Pasch, C A CA; Jeffrey, J J JJ; Clipson, L L; Matkowskyj, K A KA; Deming, D A DA
Publication Date: 2015-10-05

Variant appearance in text: KRAS: p110*
PubMed Link: 26436951
Variant Present in the following documents:
  • Main text
  • oncsis201528a.pdf
View BVdb publication page



mTOR inhibition elicits a dramatic response in PI3K-dependent colon cancers.

Plos One
Deming, Dustin A DA; Leystra, Alyssa A AA; Farhoud, Mohammed M; Nettekoven, Laura L; Clipson, Linda L; Albrecht, Dawn D; Washington, Mary Kay MK; Sullivan, Ruth R; Weichert, Jamey P JP; Halberg, Richard B RB
Publication Date: 2013

Variant appearance in text: KRAS: p110*
PubMed Link: 23593290
Variant Present in the following documents:
  • Main text
  • pone.0060709.pdf
View BVdb publication page